Daniel L. Kisner

Insider Reports History

Entity
Individual
Location
2292 Faraday Avenue, Carlsbad, CA
Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel L. Kisner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DYNAVAX TECHNOLOGIES CORP Director Common Stock 17.6K $200K $11.39 May 23, 2024 Direct
DYNAVAX TECHNOLOGIES CORP Director Stock Option (Right to Buy) 22.5K May 23, 2024 Direct
Histogen Inc. Director Stock Option (right to buy) 6.84K Jun 20, 2023 Direct
Oncternal Therapeutics, Inc. Director Stock Options 2.2K Jun 20, 2024 Direct
Zynerba Pharmaceuticals, Inc. Director Common Stock 0 $1.33 Oct 10, 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 Oct 10, 2023 Direct

Insider Reports Filed by Daniel L. Kisner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCT Oncternal Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 23, 2024 2 $0 4 May 28, 2024 Director
ZYNE Zynerba Pharmaceuticals, Inc. Oct 10, 2023 4 $0 4 Oct 11, 2023 Director
ONCT Oncternal Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
HSTO Histogen Inc. Jun 20, 2023 1 $0 4 Jun 21, 2023 Director
ZYNE Zynerba Pharmaceuticals, Inc. Jun 13, 2023 3 -$40 4 Jun 15, 2023 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2023 2 $0 4 May 31, 2023 Director
ONCT Oncternal Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
ZYNE Zynerba Pharmaceuticals, Inc. Jun 14, 2022 3 -$40 4 Jun 16, 2022 Director
HSTO Histogen Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2022 2 $0 4 May 27, 2022 Director
HSTO Histogen Inc. Sep 2, 2021 1 $0 4 Sep 3, 2021 Director
ZYNE Zynerba Pharmaceuticals, Inc. Aug 3, 2021 2 $0 4 Aug 5, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 28, 2021 1 $0 4 Jun 2, 2021 Director
ONCT Oncternal Therapeutics, Inc. May 25, 2021 1 $0 4 May 27, 2021 Director